Oral mitomycin C and UFT concomitant with irradiation in carcinoma of the cervix, stage IIb and stage IIIb.

Simple item page
dc.contributor.authorSangruchi, Supatra
dc.date.accessioned2012-04-19T09:32:37Z
dc.date.available2012-04-19T09:32:37Z
dc.date.issued1996-08
dc.description.abstractMitomycin C and UFT were given orally, concomitant with irradiation to patients with squamous and adeno-squamous cell carcinoma of the cervix, stages IIb and IIIb, at Siriraj Hospital between June 1993 and June 1994. All patients had tumours larger than 5 cm in diameter. The result showed that the patients were 100 percent disease-free for carcinoma of the cervix stage IIb and 60 percent for stage IIIb.en_US
dc.identifier.citationSangruchi Supatra. Oral mitomycin C and UFT concomitant with irradiation in carcinoma of the cervix, stage IIb and stage IIIb. Siriraj Medical Journal, 1996 Aug; 48(8): 679-682.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/137796
dc.language.isoenen_US
dc.source.urihttps://www.sirirajmedj.com/content_download.php?content_id=520en_US
dc.subjectOral mitomycin Cen_US
dc.subjectUFT concomitanten_US
dc.subjectIrradiationen_US
dc.subjectCarcinomaen_US
dc.subjectCervixen_US
dc.titleOral mitomycin C and UFT concomitant with irradiation in carcinoma of the cervix, stage IIb and stage IIIb.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
smj1996v48n8p679.pdf
Size:
1.41 MB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Siriraj Medical Journal